Perhaps the biggest shift Pharma has seen in the last 2 years is the Inflation Reduction Act (IRA) of 2022. While there are several elements to this bill, here are 3 that have a very important and immediate impact.
Medicare Drug Price Negotiation
The IRA grants Medicare the authority to negotiate prices directly with pharmaceutical companies for certain high-cost drugs. This is a major shift, as previously, Medicare was prohibited from negotiating drug prices. The team at D2 is hearing that some of these discounts might approach as much as 80%. Read More >